This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (49)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

John R. Hobbs, MD, FRCP, MRCPath

Arch Intern Med. 1975;135(1):125-130.

Abstract
There is evidence for the value of the following tests in the diagnosis, monitoring, and prognosis of myelomatosis: (1) serum paraprotein measurements, (2) urine paraprotein (including Bence Jones) measurements, (3) serum albumin, (4) serum urea, (5) proteins in the urine other than those in 2, and (6) hemoglobin level.

During treatment, increased rate of rise in 1 or 2, disproportionate increase in 2, emergence of related paraprotein, loss of 1 or 2 with reticulosarcomatous change, and monocytic leukemia suggest that more malignant subclones can emerge from the original myeloma clone, possibly due to drugs acting on DNA.

Author Affiliations
From the Department of Chemical Pathology, Westminster Medical School, London.

Footnotes
Received for publication March 7, 1974; accepted May 16.

Read before the Symposium on Myeloma, Atlanta, Oct 22, 1973.

Reprint requests to 17 Page St, London SW1P 2AR, England.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Immunoperoxidase Characterization of a Pharyngeal Plasmacytoma
Humphrey et al.
Arch Otolaryngol Head Neck Surg 1982;108:362-365.
ABSTRACT  

Multiple Myeloma in a Young Person
Kohli and Vladutiu
JAMA 1978;239:295-296.
ABSTRACT  

Mutations in Mouse Myeloma Cells: Implications for Human Multiple Myeloma and the Production of Immunoglobulins
WEITZMAN et al.
ANN INTERN MED 1976;85:110-116.
ABSTRACT